ClinicalTrials.Veeva

Menu

Effect of Short Message Service Intervention on Stent Removal/Exchange Adherence in Patients With Benign Pancreaticobiliary Diseases

A

Air Force Military Medical University of People's Liberation Army

Status

Completed

Conditions

Short Message Service
Stent Exchange
ERCP
Adherence
Biliary Stricture

Treatments

Other: Conventional reminder
Other: SMS reminder

Study type

Interventional

Funder types

Other

Identifiers

NCT02041390
20120920-5 (Other Identifier)

Details and patient eligibility

About

Endoscopic implantation of plastic or covered metal stents is widely used in a variety of benign pancreaticobiliary diseases, including duct stricture, large or difficult stones, bile or pancreatic juice leak, etc. There are some late-stage adverse events after stent insertion, such as stent occlusion, proximal or distal migration, secondary duct injury and failure of stent removal, etc. The longer the stents were inserted, more likely the adverse events would happen.

Although the optimal time of stent placement has not been well established, it has been recommended that plastic stent should be removed/exchanged within 3-4 months and covered metal stent be removed within 6 months. However, it was not uncommon that patients with stent implantation did not follow the recommendation of further stent management by endoscopists.

Many methods have been used to improve the adherence of patients in medical service. With the advance of mobile technology and popular use of mobile phones, it was believed that the patient-centered outcome could be improved by mobile telecommunication with the timely support of a patient by a health professional. Thus we hypothesize that mobile technology, reminding the patients the necessity of stent management in time by short message service (SMS), might increase the patient adherence in patients with benign pancreaticobiliary diseases after ERCP.

Enrollment

48 patients

Sex

All

Ages

80 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients more than 18 years old with plastic or covered stent implantation for the drainage of bile or pancreatic juice.

Exclusion criteria

  • primary or secondary sclerosing cholangitis;
  • malignant or suspected malignant stricture of biliary or pancreatic duct;
  • implantation of pancreatic duct stent for prevention of post-ERCP pancreatitis;
  • expected survival time less than 6 months;
  • plan of surgery within 6 months;
  • pregnant or lactating women;
  • patients who could not give informed consent.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

48 participants in 2 patient groups

SMS group
Experimental group
Description:
Patients in SMS group will receive reminding by additional SMS messages monthly after stent implantation.
Treatment:
Other: Conventional reminder
Other: SMS reminder
Conventional reminder group
Active Comparator group
Description:
Patients in control group will not receive additional SMS reminder monthly after stent implantation.
Treatment:
Other: Conventional reminder

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems